Home » Topics » BioWorld Science

BioWorld Science
RSS

Boehringer Ingelheim patents GABA(A) receptor subunits alpha5beta3gamma2 negative modulators

Feb. 10, 2020

Sumitomo Dainippon Pharma describes new Nav1.1 channel activators

Feb. 10, 2020

D6PV, a novel dual apoC-II mimetic peptide that lowers plasma triglycerides in vivo

Feb. 10, 2020

First-in-human data show safety and early hemostatic efficacy of BAY-2599023

Feb. 10, 2020

Novartis presents updated results from phase III COMBI-I study

Feb. 10, 2020

Betta Pharmaceuticals patents PD-1/PD-L1 interaction inhibitors

Feb. 7, 2020

Kleo obtains IND clearance to study KP-1237 in combination with NK cells for multiple myeloma

Feb. 7, 2020

Adial initiates pivotal phase III trial of AD-04 for alcohol use disorder

Feb. 7, 2020

Boehringer Ingelheim studies BI-905681 in phase I for advanced, unresectable or metastatic tumors

Feb. 7, 2020

Phase III trial of Fintepla in Lennox-Gastaut syndrome meets primary endpoint

Feb. 7, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...